Nurs 6521 Week 11 Case Study-Off-Label Drug Use In Pediatrics

This study source was downloaded by 100000859819779 from CourseHero.com on 01-14-2023 14:49:26 GMT -06:00https://www.coursehero.com/file/186291058/Week-11docx/ Week Eleven Assignment: Case Study-Off-Label Drug Use in Pediatrics MSN Program, Walden University NURS 6521: Advanced PharmacologyDr. Gina Banks November 11, 2022Case Study-Off-Label Drug Use in PediatricsThis study source was downloaded by 100000859819779 from CourseHero.com on 01-14-2023 14:49:27 GMT -06:00https://www.coursehero.com/file/186291058/Week-11docx/When patients use drugs for disorders other than those indicated by FDA, there can be negative consequences. Compared to adults, extensive drug evaluation in pediatrics is limited (epocrates, 2022). In fact, according to Tukayo et al., 2020, only one-third of pediatric medication undergoes clinical trials. This case study discusses considerations for off-label prescription and highlights safer ways of using off-label medicines.Considerations for off label medication use in pediatric populationsOff-label medication use involves prescribing drugs to patients without sufficient evidence to allay safety, efficacy, and cost-effectiveness concerns but within reasonable rationale for use. Due to its effectiveness, Methylphenidate, for instance, is the most common off-label drug prescribed for ADHD in children three to five years (Panther et al., 2017). Strategies for safe off-label medication use in pediatric populationsThe healthcare industry has unclear guidelines for using off-label medicines, which complicates use and may cause unwanted effects (Shuib et al.,